WeVote
Log In

Bill

Bill

SF 3087

Restrictions placed on the sale of certain over-the-counter allergy medications modifications

2025-2026 Regular Session Introduced by Liz Boldon and 1 co-sponsor

Minnesota bill restricts over-the-counter allergy medication sales, potentially requiring prescriptions and limiting consumer access to commonly used treatments.

Referred to Health and Human Services
#commerceandcommercedepartment #drugsandmedicine #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 3087

Legislative bill overview

SF 3087 would restrict the over-the-counter sale of certain allergy medications in Minnesota, likely requiring a prescription or limiting access to specific formulations or quantities. The bill was recently introduced and referred to the Health and Human Services committee for consideration.

Why is this important

Allergy medications are commonly used treatments accessed without prescriptions by millions of Minnesotans. Any restrictions could affect medication accessibility, healthcare costs for patients, and pharmacy operations across the state. The actual impact depends on which specific medications are restricted and what the restrictions entail.

Potential points of contention

  • Access and affordability: Requiring prescriptions for previously OTC medications could create barriers for patients with mild allergies and increase out-of-pocket costs
  • Public health rationale: The bill's justification for restricting these medications is unclear from available information—whether based on misuse concerns, safety data, or another factor
  • Pharmacy and retail impact: Pharmacies and retailers currently selling these medications would face operational changes and potential revenue loss

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.